| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.90M | - | |
| 10% | 32.0K | $919.6K | - | |
| VP | 19.0K | $545.7K | -16,558 | |
| CEO | 14.8K | $425.3K | - | |
| Other | 13.1K | $376.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Kihara James62 | Principal Accounting Officer | Sale+OE | 4,084 | $23.69 | $96,753.64 | -14.0% | -3.6% | - | |
| Nov 10, 2025 | Daly James M | Director | Sell | 30,000 | $22.37 | $670,983.00 | -88.1% | +4.6% | - | |
| Sep 15, 2025 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sell | 3,498 | $23.65 | $82,727.70 | -7.5% | +10.5% | - | |
| Sep 2, 2025 | Garofalo Elizabeth A.50 | Director | Sell | 1,600 | $25.98 | $41,560.48 | -5.9% | -3.3% | - | |
| Aug 18, 2025 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sell | 22,000 | $25.18 | $554,023.80 | -35.4% | -4.2% | - | |
| Jun 4, 2025 | Brege Laura62 | Director | Sell | 14,446 | $21.78 | $314,633.88 | -48.9% | +18.0% | - | |
| May 16, 2025 | Kihara James62 | Principal Accounting Officer | Sell | 4,000 | $22.50 | $90,000.00 | -8.5% | +10.2% | - | |
| May 16, 2025 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sell | 2,000 | $25.00 | $50,000.00 | -3.1% | +10.2% | - | |
| May 2, 2025 | Kihara James62 | Principal Accounting Officer | Sale+OE | 1,327 | $14.60 | $19,374.20 | -5.3% | +59.8% | - | |
| May 2, 2025 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 3,498 | $14.60 | $51,070.80 | -5.3% | +59.8% | - |